Neurology Minute
1,925 episodes — Page 10 of 39
Blood Biomarkers to Detect Alzheimer Disease - Part 1
In part one of this two-part series, Dr. Gregg Day and Dr. Sebastian Palmqvist discuss the top-line findings from the study exploring the diagnostic performance of blood biomarkers for Alzheimer disease in clinical cohorts. Show reference: https://jamanetwork.com/journals/jama/fullarticle/2821669
Blood Biomarkers to Detect Alzheimer Disease - Part 1
In part one of this two-part series, Dr. Gregg Day and Dr. Sebastian Palmqvist discuss the top-line findings from the study exploring the diagnostic performance of blood biomarkers for Alzheimer disease in clinical cohorts. Show reference: https://jamanetwork.com/journals/jama/fullarticle/2821669
Outcomes of Patients With MCI With Lewy Bodies or Alzheimer Disease - Part 1
In part one of this two-part series, Dr. Jeff Ratliff and Dr. Calium discuss the risk of developing dementia among patients with MCI at three or five-year time points. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000209499
New Treatment Option for Parkinson Disease
Dr. Jeff Ratliff talks about the FDA approval of Crexont for the treatment of Parkinson disease. Show reference: https://jamanetwork.com/journals/jamaneurology/fullarticle/2808496
Chronic Adaptive Deep Brain Stimulation Versus Conventional Stimulation in Parkinson Disease
Dr. Jeff Ratliff discusses an exciting study in the world of deep brain stimulation for Parkinson disease. Show reference: https://www.nature.com/articles/s41591-024-03196-z
Efficacy of Atogepant in Chronic Migraine With and Without Acute Medication Overuse
Dr. Tesha Monteith talks about the efficacy of atogepant for the preventive treatment of chronic migraine in participants with and without acute medication overuse. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000209584
Neuropsychological Profiles of Deployment-Related mTBI
Dr. Stacey Clardy and Dr. Nicola de Souza discuss how to improve care in the clinic for these veterans and military service members. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000209417
Long-Term Dementia Risk in Parkinson Disease - Part 1
In the first installment of this two-part series, Dr. Jeff Ratliff and Dr. Daniel Weintraub discuss the risks associated with the development of dementia in patients diagnosed with Parkinson disease. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000209699
Interpreting DAT Imaging Results in the Clinical Context - Part 2
In part two of this two-part series, Dr. Jeff Ratliff and Dr. Eduardo De Pablo-Fernández discuss why clinicians should be cautious when relying too much on dopaminergic imaging. Show reference: https://doi.org/10.1212/WNL.0000000000209453
Understanding Long COVID - Part 2
In part two of this two-part series, Dr. Tesha Monteith discusses the key features of long COVID. Show reference: https://doi.org/10.17226/27768
Understanding Long COVID - Part 1
In part one of this two-part series, Dr. Tesha Monteith discusses the 2024 National Academies of Sciences, Engineering, and Medicine formal definition of long COVID. Show reference: https://doi.org/10.17226/27768
Interpreting DAT Imaging Results in the Clinical Context
Dr. Jeff Ratliff and Dr. Eduardo De Pablo-Fernández discuss the strengths of dopamine transporter imaging or DAT imaging in diagnosing patients with Parkinsonian disorders. Show references: https://doi.org/10.1212/WNL.0000000000209453
New Data and New Controversies on Cardiac Monitoring and Anticoagulation - Part 1
Dr. Dan Ackerman and Dr. Luciano A. Sposato discuss the topic of embolic stroke of undetermined sources and the controversies surrounding cardiac monitoring and anticoagulation. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000209535
AHS Position Statement
Dr. Tesha Monteith provides an overview of the updated position statement on migraine prevention by the American Headache Society.
Bridging Therapy With Tenecteplase or Alteplase in Patients With Large Ischemic Core - Part 2
In part two of this two-part series, Dr. Dan Ackerman and Dr. Gaspard Gerschenfeld discuss the differences in treatment between American Stroke Centers and those in France. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000209398
Transient Smartphone Blindness
Dr. Meagan Seay discusses a relatively recently described but very interesting phenomenon called transient smartphone blindness. This is a phenomenon causing acute, painless, transient, monocular vision loss associated with smartphone use while lying down in the dark. Show reference: Transient Smartphone Blindness - EyeWiki
Bridging Therapy With Tenecteplase or Alteplase in Patients With Large Ischemic Core
Dr. Dan Ackerman and Dr. Gaspard Gerschenfeld discuss the efficacy and safety of both thrombolytics in patients with large ischemic core. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000209398
The Ethical Landscape of Prodromal Parkinson Disease
Dr. Jason Crowell and Dr. Colin Hoy discuss the concept of prodromal Parkinson disease and the ethical considerations surrounding its diagnosis. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000209522
Movement Disorders Emergencies - Part 3
In the last episode of this three-part series, Dr. Jeff Ratliff discusses how to approach patients presenting with emergent rigidity and difficulty moving.
Movement Disorders Emergencies - Part 2
In the second episode of this three-part series, Dr. Jeff Ratliff provides a rapid overview of hyperkinetic disorders that require urgent attention.
Movement Disorders Emergencies - Part 1
In the first episode of this three-part series, Dr. Jeff Ratliff discusses a few key points to help recognize and initiate treatment for patients with movement disorder emergencies, focusing on the initial approach to these disorders. It is important to consider medications, labs, and imaging as part of the evaluation process.
Association of Prenatal Exposure to Antiseizure Medications
Dr. Halley Alexander and Dr. Kimford Meador discuss perinatal exposure to anti-seizure medications and its effects on creativity and executive function in children. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000209448
Tapping the Brakes on New Parkinson Disease Biological Staging
Dr. Matthew Barrett and Dr. Michael S. Okun discuss the caution and deliberation needed in understanding Parkinson disease biomarkers. Show reference: https://jamanetwork.com/journals/jamaneurology/article-abstract/2820441
Biologic Therapies Approved for the Treatment of Generalized Myasthenia Gravis - Part 2
In the final episode of this two-part series, Dr. Joe Conway will discuss four biologic therapies that have been approved in recent years by the FDA for the treatment of adults with generalized myasthenia gravis. In this episode, he will talk about two of the treatment medications: Ravulizumab + zilucoplan. Show references: https://doi.org/10.1016/s1474-4422(21)00159-9 https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(23)00077-7/abstract
Large Language Models for Quality and Efficiency of Neurologic Care - Part 2
In the final part of this two-part series, Dr. Andy Southerland and Dr. Lidia Moura discuss strategies on how clinicians can mitigate bias when using large language models. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000209497
Transcobalamin Receptor Antibodies in Autoimmune Vitamin B12 Central Deficiency - Part 2
Dr. Justin Abbatemarco, Dr. Michael R. Wilson, and Dr. John Pluvinage discuss their discovery of anti-CD320 antibodies in patients with neurologic manifestations of B12 deficiency and discuss the potential implications for diagnosis and treatment. Show reference: https://www.science.org/doi/10.1126/scitranslmed.adl3758
Large Language Models for Quality and Efficiency of Neurologic Care - Part 1
In part one of the part-two series, Dr. Andy Southerland and Dr. Lidia Moura discuss the major findings related to large language models (LLMs) for neurologic care. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000209497
Transcobalamin receptor Antibodies in Autoimmune Vitamin B12 Central Deficiency
Dr. Justin Abbatemarco, Dr. Michael R. Wilson, and Dr. John Pluvinage introduce B12 deficiency and discuss challenges in measuring B12 levels in the serum. Show reference: https://www.science.org/doi/10.1126/scitranslmed.adl3758
Biologic Therapies Approved for the Treatment of Generalized Myasthenia Gravis - Part 1
In the first episode of a two-part series, Dr. Joseph Conway will discuss four biologic therapies that have been approved in recent years by the FDA for the treatment of adults with generalized myasthenia gravis. In this episode, he will talk about two of the treatment medications: Efgartigimod and Rozanolixizumab. Show references: https://doi.org/10.1016/s1474-4422(21)00159-9 https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(23)00077-7/abstract
Women History Minute - Marian Molly Putnam
Dr. Alison Christy delves into another women's history minute to discuss Marian Molly Putnam.
Understanding Apathy in Parkinson Disease - Part 2
Dr. Jason Crowell and Dr. Campbell Le Heron discuss tips and recommendations to help improve apathy in folks with Parkinson disease. Show references: https://www.neurology.org/doi/10.1212/WNL.0000000000209301
Understanding Apathy in Parkinson Disease - Part 1
Dr. Jason Crowell and Dr. Campbell Le Heron discuss trying to assess for apathy in folks with Parkinson disease. Show references: https://www.neurology.org/doi/10.1212/WNL.0000000000209301
Paraneoplastic CAMKV Autoimmune Encephalitis
Dr. Justin Abbatemarco and Dr. Andrew McKeon discuss the topic of autoimmune neurology, specifically focusing on the antibody CAMKV and its association with autoimmune encephalitis. Show reference: https://pubmed.ncbi.nlm.nih.gov/38634529/
Women History Minute - Mary Putnam Jacobi
Dr. Alison Christy delves into another women's history minute to discuss Mary Putnam Jacobi.
An Angiotensin Receptor Blocker for Hypertension Is Associated With a Reduced Risk for Epilepsy
Dr. Halley Alexander discusses the Neurology Today article, "An Angiotensin Receptor Blocker for Hypertension Is Associated With a Reduced Risk for Epilepsy," available in the July 18th issue of Neurology Today or at neurologytoday.com. Show reference: https://pubmed.ncbi.nlm.nih.gov/38884986/
Systematic Review of Individuals with Seropositive MOGAD
Dr. Jodie Roberts discusses a systematic review of individuals with Seropositive MOGAD presented at the 2024 Australian and New Zealand Association of Neurologists Annual Scientific Meeting. Learn more about the Neurology Practice Current section or fill out the survey now.
Epidural Patching Outcomes and Predictors of Benefit in Patients With Suspected CSF Leak
Dr. Jessica Ailani and Dr. Ian Carroll discuss intracranial hypotension, the challenges of diagnosing and treating patients with CSF leaks, and the study's findings. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000209449 This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
Physician as Patient Series - Multiple Sclerosis
As part of our "Physician as Patient" series, Dr. Andy Southerland talks with Dr. Eric Seachrist about his experience with multiple sclerosis. This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
Physician as Patient Series - Multiple Sclerosis
As part of our "Physician as Patient" series, Dr. Andy Southerland talks with Dr. Eric Seachrist about his experience with multiple sclerosis. This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
Women History Minute - Ema Gibbs
Dr. Alison Christy delves into another women's history minute to discuss Ema Gibs. This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
Women History Minute - Marie Joubert
Dr. Alison Christy delves into another women's history minute to discuss Marie Joubert. This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
Women History Minute - Mary Spink and Alice Bennett
Dr. Alison Christy delves into another women's history minute to discuss Mary Spink and Alice Bennett. This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
Talk with AAN President
Dr. Stacey Clardy and Dr. Carlayne E. Jackson discuss the state of neurology and the challenges and opportunities facing the field. This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
Highlights of the 2024 European Stroke Organization Conference
Dr. Andy Southerland and Dr. Seemant Chaturvedi discuss recent trials presented at the European Stroke Organization Conference. Show references: Tenecteplase for Ischemic Stroke at 4.5 to 24 Hours without Thrombectomy Rationale and Design of Tenecteplase Reperfusion Therapy in Acute Ischaemic Cerebrovascular Events III (TRACE III) Colchicine for Prevention of Vascular Inflammation in Non-CardioEmbolic Stroke (CONVINCE) Intensive Ambulance-Delivered Blood- Pressure Reduction in Hyperacute Stroke This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
Association between Radiographic Features of Hypertrophic Pachymeningitis and its Underlying Diagnoses
Dr. Justin Abbatemarco and Dr. Jiyeon Son discuss her paper "Association between Radiographic Features of Hypertrophic Pachymeningitis and its Underlying Diagnoses." Show reference: https://www.aan.com/conferences-community/summer-conference/abstracts/ This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
Prospective Study Presents Longitudinal Trajectory of Cognitive Impairment in Patients With Essential Tremor
Dr. Halley Alexander discusses the Neurology Today article, "Prospective Study Presents Longitudinal Trajectory of Cognitive Impairment in Patients With Essential Tremor" by Susan Kreimer, available in the June 20th issue of Neurology Today or at neurologytoday.com. Show reference: https://journals.lww.com/neurotodayonline/fulltext/2024/06200/prospective_study_presents_longitudinal_trajectory.2.aspx This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
Neurologic Outcomes in People with Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder Exposed To Immune Checkpoint Inhibitors
Dr. Shuvro Roy and Dr. Alexander Gill discuss his paper "Neurologic Outcomes in People with Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder Exposed To Immune Checkpoint Inhibitors." Show reference: https://www.aan.com/conferences-community/summer-conference/abstracts/ This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
Refractory Headache Part 3
Dr. Tesha Monteith and Dr. Michael Marmura discuss tips on how to treat refractory headaches.
AAN Brain Health Initiative
Dr. Stacey Clardy and Dr. Natalia Rost discuss the AAN brain health initiative. Show reference: https://www.aan.com/tools-resources/brain-health
CSF Metagenomics and Host Transcriptomics of Cryptogenic New-onset Refractory Status Epilepticus
Dr. Shuvro Roy and Dr. Mary Karalius discuss her paper "CSF Metagenomics and Host Transcriptomics of Cryptogenic New-onset Refractory Status Epilepticus." Show reference: https://www.aan.com/conferences-community/summer-conference/abstracts/